Search Results
Dr Karthik S | Udupa Real world Evidence Osimertinib as SoC in the management of EGFRm NSCLC
Col Dr G S Chaudhary | Real World Evidence Osimertinib as SoC in the management of EGFRm NSCLC
Dr. Ramalingam on the Use of Osimertinib in Clinical Trial and Real-World Settings
EGFR Mutated NSCLC Disease Progression on Osimertinib - 2022 Program: Targeted Therapies Forum
Osimertinib and the FLAURA Trial
Dr Aparna Dhar | Role of Biomarkers in the management of advanced NSCLC
The Ultimate Guide to Osimertinib: How it Works, Uses, and Managing Side Effects
Dr Vamshi Krishna | Osimertinib vs Dacomitinib
Frontiers in Oncology: Tarec El-Galaly, DMSc
Dr Nagender Sharma | Targeting EGFR Exon 19 & Exon 21
September 24, 2022, Revolution Cancer International Molecular Tumor Board- NOVARTIS, MET, mdm2, MSI
Understanding PCOS and Fertility: Expert Insights with Dr. Vineetha Udupa
